mRNA多-HLAII类 黑色素瘤的免疫疗法
Apostolos P Georgopoulos1,2,3, Lisa M James1,2,4, Matthew Sanders1,2,3
1The HLA Cancer Research Group, Brain Sciences Center, Department of Veterans Affairs Health Care System, Minneapolis VAMC, One Veterans Drive, Minneapolis, MN 55417, USA.
Cells
|September 26, 2025
概括
研究人员从结合人类白细胞抗原II类分子的黑色素瘤蛋白中鉴定出679个高抗原性表位. 这些-HLAII类复合物显示出开发新型癌症疫苗和治疗方法的前景.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 计算生物学 计算生物学
背景情况:
- 人类白细胞抗原 (HLA) 类II分子向CD4+T细胞呈现,启动免疫反应.
- 类对HLA-II的高亲和结合对于T细胞激活和随后的免疫功能至关重要.
- 与黑色素瘤相关的蛋白质含有类,当由HLA-II呈现时,它们具有作为抗瘤剂的潜力.
研究的目的:
- 从黑色素瘤相关蛋白中计算识别高亲和性-HLAII类 (pHLA-II) 复合体.
- 发现用于开发新型癌症免疫疗法的强有力的表征物.
主要方法:
- 从15种黑色素瘤抗原对192种常见的HLA-II分子的所有可能的15-mer的结合亲和力 (IC50) 的in silico预测.
- 对665,472个pHLA-II对进行分析,以确定具有强烈预测结合亲和力 (PBBA IC50 < 50 nM) 的对.
主要成果:
- 确定了5941个具有强烈预测结合亲和力的pHLA-II对,占所有测试对的0.89%.
- 这些高亲和度结合剂起源于117个HLA-II等位基因和679个不同的表位基因.
- 已识别的表位和相应的HLA-II分子适合多疫苗开发.
结论:
- 鉴定出的679个高抗原性表位可用于设计有效的癌症疫苗.
- 单独或与HLA-II分子一起使用这些表位素可以刺激CD4+ T辅助细胞,增强CD8+ T细胞功能,并诱导抗瘤抗体.
- 这种方法对治疗黑色素瘤和其他固体瘤充满希望,免疫检查点抑制剂可能会增强这种方法.
更多相关视频
09:53Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
Published on: February 6, 2017
11.8K
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.9K
相关概念视频
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Antigens Involved in Adaptive Immunity
1.3K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.3K
